NEW YORK, N.Y., November 2, 2015 - Pfizer Inc. announced today that 26 new scientific abstracts, including 20 presentations for XELJANZ® (tofacitinib citrate) in rheumatoid arthritis (RA ...

Xeljanz plus MTX. Pfizer has announced top-line results from its Phase 3B/4 study comparing treatment with Xeljanz (tofacitinib citrate) to adalimumab in patients with moderate to severe ...

Pfizer announced top-line results from the OPAL Beyond study, the second Phase 3 trial of Xeljanz (tofacitinib citrate) for the potential treatment of patients with active psoriatic arthritis (PsA).

(That name you probably know how to say.) Though awkward to pronounce, Xeljanz is more memorable than its generic name, tofacitinib citrate. And it’s much more noteworthy than its chemical name ...

Researchers conducted two independent evaluations related to Xeljanz (tofacitinib citrate, Pfizer) treatment of patients with rheumatoid arthritis (RA). All patients met the 1987 American College ...

or in the axillae or groin,” was administered 10 mg daily of Tofacitinib Citrate (more commonly referred to by its brand name, XELJANZ) for the first two months; the dosage was then increased to ...

When King examined the patient, he thought that both diseases could be addressed with the use of a single drug for rheumatoid arthritis called tofacitinib citrate. The drug had been used to treat ...

Pfizer’s Arthritis Drug Xeljanz (tofacitinib citrate) should not be approved for the treatment of rheumatoid arthritis, CHMP (Committee for Medicinal Products for Human Use) advised the European ...

Researchers found that more than 50 percent of 66 patients treated with the drug Xeljanz (tofacitinib citrate) saw hair regrowth in three months. “There is hope now that we will have more to ...

King believed it might be possible to address both diseases simultaneously using an existing FDA-approved drug for rheumatoid arthritis called tofacitinib citrate. The drug had been used successfully ...

Doctors at Yale University tried an unusual treatment using an FDA-approved drug, tofacitinib citrate, which is designed to treat the autoimmune disease rheumatoid arthritis. The patient was able ...